Page last updated: 2024-11-01

ondansetron and Coronary Artery Disease

ondansetron has been researched along with Coronary Artery Disease in 1 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lewandowski, MJ1
Chapman, SA1

Reviews

1 review available for ondansetron and Coronary Artery Disease

ArticleYear
Ondansetron-induced aminotransferase level elevation: case report and review of the literature.
    Pharmacotherapy, 2008, Volume: 28, Issue:12

    Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Coronary Artery Disease; Female; Humans; I

2008